A Single-Center, Prospective Phase II Clinical Study of Proton Beam Intensity-Modulated Stereotactic Radiotherapy for Early-Stage Non-Small Cell Lung Cancer

Conditions

• Early-Stage Lung Cancer
• Lung Cancer

Interventions

• RADIATION: Stereotactic Body Proton Therapy

Sponsor

Guangzhou Concord Cancer Center